Eton Pharmaceuticals (ETON) Insider Trading & Ownership $9.56 -0.90 (-8.60%) (As of 10:15 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Eton Pharmaceuticals (NASDAQ:ETON) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage14.89%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$462,673.60Number OfInsiders Selling(Last 12 Months)0 Get ETON Insider Trade Alerts Want to know when executives and insiders are buying or selling Eton Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ETON Insider Buying and Selling by Quarter Ad TradingTips7 Cheap and Good StocksIt's the holy grail of the stock market... Stocks that trade for pennies on the dollar yet have the potential to skyrocket for monster gains. Well, we've uncovered SEVEN such stocks.Simply follow this link and claim your copy today at no charge whatsoever. Eton Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/7/2024Opaleye Management Inc.Major ShareholderBuy11,248$7.22$81,210.56 10/4/2024Opaleye Management Inc.Major ShareholderBuy16,852$6.77$114,088.04 9/10/2024Opaleye Management Inc.Major ShareholderBuy57,500$4.65$267,375.00 (Data available from 1/1/2013 forward) ETON Insider Trading Activity - Frequently Asked Questions Who is on Eton Pharmaceuticals's Insider Roster? The list of insiders at Eton Pharmaceuticals includes Opaleye Management Inc., and Sean Brynjelsen. Learn more on insiders at ETON. What percentage of Eton Pharmaceuticals stock is owned by insiders? 14.89% of Eton Pharmaceuticals stock is owned by insiders. Learn more on ETON's insider holdings. Which Eton Pharmaceuticals insiders have been buying company stock? The following insider purchased ETON shares in the last 24 months: Opaleye Management Inc. ($462,673.60). How much insider buying is happening at Eton Pharmaceuticals? Insiders have purchased a total of 85,600 ETON shares in the last 24 months for a total of $462,673.60 bought. Eton Pharmaceuticals Key ExecutivesMr. Sean E. Brynjelsen (Age 52)President, CEO & Director Compensation: $939.42kMr. James R. Gruber CPA (Age 52)CFO, Treasurer & Secretary Compensation: $554.44kMr. David C. Krempa (Age 35)Chief Business Officer Compensation: $547.86kMs. Ingrid HoosSenior Vice President of Regulatory AffairsMr. Kevin GuthrieExecutive VP of Commercial Operations More Insider Trading Tools from MarketBeat Related Companies LXRX Insider Trades ASMB Insider Trades GLYC Insider Trades ERAS Insider Trades DNTH Insider Trades EOLS Insider Trades TYRA Insider Trades REPL Insider Trades RLAY Insider Trades AVXL Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:ETON) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eton Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.